Enhanced diuretic action of furosemide by complexation with β-cyclodextrin in the presence of sodium lauryl sulfate
Preparation of inclusion complex using cyclodextrins is a well-known formulation strategy to elevate the solubility of drugs. However, often cyclodextrins alone may not bring a considerable improvement in the solubility of low solubility drugs. In this study, the inclusion complexation of furosemide (FSM) was tried with β-cyclodextrin (β-CD) either with the use or without the use of sodium lauryl sulfate (SLS), which is a surfactant. By using the kneading method, the binary complex of FSM/β-CD in the equal molar ratio was used. FSM and β-CD were kneaded continuously until a thick past was achieved, which was evaporated for a period of about 24 h. The solid complexed product was then crushed and stored in airtight container until use. Phase solubility studies confirmed a stoichiometric ratio of 1:1 (FSM/β-CD and FSM/β-CD with SLS). The apparent stability constant and complexation efficiencies of significantly enhanced in the presence of SLS. The prepared complexes were evaluated for DSC, PXRD, 1H NMR, and in vitro release studies. The results exhibited a significant enhancement in diuresis in rats. It is evident that the addition of SLS with β-CD significantly enhances the solubilizing efficiencies and hence bioavailability of FSM..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
De Gruyter ; 2020 |
| Reproduktion: |
Walter de Gruyter Online Zeitschriften |
|---|---|
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
| Enthalten in: |
Green processing & synthesis - 9(2020), 1 vom: 15. Dez., Seite 744-750 |
| Beteiligte Personen: |
Al-Shdefat, Ramadan I. [VerfasserIn] |
|---|
| Links: |
doi.org [Deutschlandweit zugänglich] |
|---|
| Themen: |
|---|
| Umfang: |
7 |
|---|
| doi: |
10.1515/gps-2020-0069 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLEJ248008374 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ248008374 | ||
| 003 | DE-627 | ||
| 005 | 20230506090301.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220814s2020 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1515/gps-2020-0069 |2 doi | |
| 028 | 5 | 2 | |a articles2015-2020.pp |
| 035 | |a (DE-627)NLEJ248008374 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a Al-Shdefat, Ramadan I. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enhanced diuretic action of furosemide by complexation with β-cyclodextrin in the presence of sodium lauryl sulfate |
| 264 | 1 | |b De Gruyter |c 2020 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Preparation of inclusion complex using cyclodextrins is a well-known formulation strategy to elevate the solubility of drugs. However, often cyclodextrins alone may not bring a considerable improvement in the solubility of low solubility drugs. In this study, the inclusion complexation of furosemide (FSM) was tried with β-cyclodextrin (β-CD) either with the use or without the use of sodium lauryl sulfate (SLS), which is a surfactant. By using the kneading method, the binary complex of FSM/β-CD in the equal molar ratio was used. FSM and β-CD were kneaded continuously until a thick past was achieved, which was evaporated for a period of about 24 h. The solid complexed product was then crushed and stored in airtight container until use. Phase solubility studies confirmed a stoichiometric ratio of 1:1 (FSM/β-CD and FSM/β-CD with SLS). The apparent stability constant and complexation efficiencies of significantly enhanced in the presence of SLS. The prepared complexes were evaluated for DSC, PXRD, 1H NMR, and in vitro release studies. The results exhibited a significant enhancement in diuresis in rats. It is evident that the addition of SLS with β-CD significantly enhances the solubilizing efficiencies and hence bioavailability of FSM. | ||
| 533 | |f Walter de Gruyter Online Zeitschriften | ||
| 650 | 4 | |a furosemide | |
| 650 | 4 | |a cyclodextrin | |
| 650 | 4 | |a complex | |
| 650 | 4 | |a solubility | |
| 650 | 4 | |a diuretic activity | |
| 773 | 0 | 8 | |i Enthalten in |t Green processing & synthesis |d Berlin : De Gruyter, 2012 |g 9(2020), 1 vom: 15. Dez., Seite 744-750 |w (DE-627)NLEJ248235648 |w (DE-600)2645923-1 |x 2191-9550 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2020 |g number:1 |g day:15 |g month:12 |g pages:744-750 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1515/gps-2020-0069 |z Deutschlandweit zugänglich |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DGR | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2020 |e 1 |b 15 |c 12 |h 744-750 |g 7 | ||